Skip to Main content Skip to Navigation
Journal articles

Is it time to reconsider initial antibiotic treatment strategies for severe urinary tract infections in Europe?

Abstract : Until recently, most reported cases of bacteraemia caused by multidrug-resistant strains of Enterobacteriacae producing an extended-spectrum b-lactamase (ESBL) in Europe have been nosocomial in origin. However, increasing numbers of reports of community-acquired bacteraemia and urinary tract infection caused by ESBL-producing microorganisms suggest that the geographical origin of patients should be taken into account as a risk-factor for possible ESBL production. Early identification of patients at highrisk of infection with ESBL-producing microorganisms, based on their geographical origin and travel history, should help to optimise initial antibiotic treatment strategies for severe urinary tract infections in Europe.
Complete list of metadata

https://hal-pasteur.archives-ouvertes.fr/pasteur-03204201
Contributor : Andrée Diakite <>
Submitted on : Wednesday, April 21, 2021 - 1:30:31 PM
Last modification on : Saturday, July 17, 2021 - 3:42:29 AM

Links full text

Identifiers

Collections

Citation

J.R. Zahar, M. Lecuit, E. Carbonnelle, F. Ribadeau-Dumas, X. Nassif, et al.. Is it time to reconsider initial antibiotic treatment strategies for severe urinary tract infections in Europe?. Clinical Microbiology and Infection, Elsevier for the European Society of Clinical Microbiology and Infectious Diseases, 2007, 13 (3), pp.219-221. ⟨10.1111/j.1469-0691.2007.01666.x⟩. ⟨pasteur-03204201⟩

Share

Metrics

Record views

7